Li Mao

Li Mao currently works at Legend Biotech Corp., as Independent Director from 2022.
Dr. Mao also formerly worked at Xcovery Holding, Inc., as Chief Executive Officer from 2018 to 2021, Livzon Pharmaceutical Group, Inc., as Chief Executive Officer in 2021, Betta Pharmaceuticals Co., Ltd., as Director, Chief Medical Officer & Senior VP from 2018 to 2021, Sino Biopharmaceutical Ltd., as Chief Medical Officer from 2021 to 2022, SciClone Pharmaceuticals (China) Co. Ltd., as Chief Medical Officer from 2022 to 2025, Johnson & Johnson, as Vice President from 2016 to 2018, The University of Texas M.D.
Anderson Cancer Center, as Professor from 2004 to 2009, and the University of Maryland Baltimore County, as Professor from 2009 to 2016.
Dr. Mao received his doctorate degree from Nanjing Medical University.